SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is trending as investors weigh strong operational performance and raised revenue guidance against ongoing frustration with share price volatility and persistent market skepticism. The community is actively debating the company's long-term growth potential versus the impact of macroeconomic headwinds, with many focusing on whether recent records in member and loan growth will finally translate into sustained upward price momentum.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is seeing intense market volatility and heavy trading volume as investors brace for earnings, with the community closely tracking whether the firm's pivot to powering AI data centers will justify recent valuation swings. While some traders are aggressively buying the dip on strong institutional interest, others are remaining cautious, pointing to ongoing short-seller narratives and the stock's significant decline from previous highs.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is currently trending as investors debate whether the recent sharp pullback is an overdone reaction to lowered guidance and restructuring costs or a sign of deeper structural issues. The community is actively discussing potential bottom-fishing opportunities, debating the stock's valuation relative to its med-tech peers, and closely monitoring institutional accumulation and dark pool activity as they await the next earnings report.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. The firm also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment includes products and services sold for applications within the data center, communication networks and commercial and industrial markets in North America and Latin America. The Asia Pacific segment consists of products and services sold for applications within the data center, communication networks and commercial and industrial markets throughout Greater China, Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Westerville, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertiv Holdings is experiencing significant volatility as investors weigh the stock's massive year-to-date gains against concerns over high valuation multiples and profit-taking ahead of its upcoming investor conference. While the community remains largely bullish on Vertiv's long-term leadership in AI data center cooling and power infrastructure, the stock is currently undergoing a technical correction as market participants debate whether the rapid valuation expansion is supported by near-term earnings growth.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors brace for a critical FDA Advisory Committee meeting regarding its DMD therapy, deramiocel, following briefing documents that questioned the company's statistical analysis plans. The community is deeply divided and highly volatile, with intense debate over whether the FDA's critique constitutes a valid regulatory concern or a bureaucratic overreach, while advocates emphasize the potential life-extending impact of the drug on patients.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford Motor Co is trending following a strong quarterly earnings report that featured a revenue and adjusted EPS beat alongside raised full-year guidance, fueling investor optimism despite ongoing EV segment losses. Community discussion is heavily focused on the stock's potential for a short squeeze, its role as a dividend-paying blue chip, and debates over whether this earnings performance signals a sustainable turnaround for the automaker.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending following a new multi-program partnership with Jazz Pharmaceuticals focused on its T-cell engager platform, which investors see as a significant validation of its discovery engine. The community is heavily focused on the company's long-term pivot toward developing its own internal pipeline, with active discussions debating whether the stock's current consolidation and high short interest signal a setup for a major breakout or continued volatility ahead of upcoming clinical data.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin shares are experiencing heightened volatility as investors weigh the potential impact of an upcoming Supreme Court ruling on the Hikma patent dispute alongside anticipation for the company's first-quarter earnings report. Community sentiment is deeply divided, with many long-term shareholders expressing frustration over stagnant performance, while others are closely monitoring clinical developments and strategic patent filings for signs of a future buyout catalyst.

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Humana Inc.

Humana Inc

Humana is trending following a strong quarterly earnings beat and a strategic board shakeup involving the appointment of new directors from Anthropic and Aflac. While the company reaffirmed its fiscal year adjusted profit outlook, investors are closely monitoring the stock's performance amid ongoing concerns regarding Medicare Advantage cost trends, star ratings, and the potential impact of regulatory shifts.

Lemonade, Inc. is a holding company, which engages in the provision of insurance services. The firm's products include renters and homeowners insurance, and pet insurance. It offers insurance coverage under the homeowners multi-peril, inland marine, and general liability lines of business. The company was founded by Daniel Asher Schreiber and Shai Wininger on June 17, 2015 and is headquartered in New York, NY.

Lemonade Inc

Lemonade is seeing high volatility and intense debate following strong earnings that highlighted revenue growth and improved underwriting, yet triggered a sharp sell-off as investors prioritize durable profitability over growth metrics. While community sentiment remains split between long-term bulls highlighting AI-driven operational leverage and bears skeptical of continued net losses, many are actively using the price dip to establish or expand positions in anticipation of a potential rebound.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


big777vn

big777vn big777vn